Clinical pharmacists are reshaping clinical trial supply from forecasting to dispensing enabling adaptive trials decentralized deliverypatientcentric manufacturing shift.
- The Hidden Operational Complexities Of Home Infusion
- Building Resilient Clinical Trial Supply Chains In An Era Of Geopolitical Risk
- Site-Level Execution In Clinical Trials: Where Systems Break Down
- Blind Spots And Blocked Ports: Surviving Clinical Supply Friction In LATAM And APAC
- Truth: Clinical Supply Is Often The First To See The Whole Picture
- The $122 Billion Question: Can Clinical Trial Supply Systems Keep Pace With Cell Therapy Demand?
- From Individual Shipments To Patterns: How Compliance Is Understood Over Time
- Geopolitical Risk Is Reshaping Clinical Trial Supply Chains
ON-DEMAND WEBINARS
This panel webinar discusses the importance of clinical supply agility and how to mitigate supply chain risk that comes along with clinical supply decisions.
Learn how demand-led and hybrid clinical supply models reduce waste, accelerate timelines, and improve flexibility for global trials through regional hubs and patient-specific packaging strategies.
Discover how to transform logistical challenges into strategic advantages with flexible, forward-looking solutions designed for today’s dynamic clinical development landscape.
Learn about strategies that can help build an understanding of risk assessment, in addition to how a study’s protocol requirements, packaging specifications, and more must be identified and addressed.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![2026 start button-GettyImages-2232020388]( "How Life Sciences Leaders Are Preparing For More Curveballs In 2026")
How Life Sciences Leaders Are Preparing For More Curveballs In 2026Anticipate regulatory shifts and supply chain hurdles with agile scenario planning. Move beyond fragmented systems to build a resilient, data-driven foundation for a volatile industry landscape.
-
![GettyImages-1163506017 labeling]( "IMP Labeling: EU CTR Transition Considerations")
IMP Labeling: EU CTR Transition ConsiderationsReview current requirements as outlined by the EU Clinical Trial Regulation, supporting guidance, and three key considerations when planning IMP labeling activities for ongoing studies.
-
![GettyImages-1334686671-cold-chain-cryopreservation-logistics]( "Overcoming The Challenge Of Maintaining Sterility At Low Temperature Storage")
Overcoming The Challenge Of Maintaining Sterility At Low Temperature StorageLearn about a biotech company with a recently approved gene therapy product that needed to select a packaging solution to meet their needs for storage at low temperatures and still get to market quickly.
-
![Ampoule Aseptic Filling GettyImages-1490244818]( "Advantages Of Robotic Aseptic Processing")
Advantages Of Robotic Aseptic ProcessingExamine the robotic technologies poised to increase manufacturing flexibility and efficiency while minimizing risk when bringing biologics to market.
-
![cdmo-drug-assembly-manual-GettyImages-1339603591]( "Manual Assembly Strategies For Early‑Phase Combination Product Supply")
Manual Assembly Strategies For Early‑Phase Combination Product SupplyEarly‑phase combination products rely on manual assembly. Clear process design, quality controls, and collaboration help clinical supply teams reduce risk and maintain trial‑ready flexibility.
-
![expensive healthcare, drug container, pills-GettyImages-171587042]( "Navigating The Biopharma Finance And Accounting Tech Landscape")
Navigating The Biopharma Finance And Accounting Tech LandscapeDuring clinical trials, the intricacies of financial management intensify, necessitating advanced ERP functionalities to handle clinical accruals, compliance, and reporting.
-
![GettyImages-2195589370-clinical-development-group-tablet-table]( "How To Build Effective Clinical Trial Oversight And Leadership")
How To Build Effective Clinical Trial Oversight And LeadershipIn a collaborative outsourcing model, the sponsor maintains direct contact with functional leads, eliminating communication gaps and enabling faster, better-informed decision-making.
-
![BO 2 - GC_App_^CZ vial with stopper and seal stack up]( "Bringing A Biosimilar For Oncology To Market: Injectable Packaging From Early Development To Commercialization")
Bringing A Biosimilar For Oncology To Market: Injectable Packaging From Early Development To CommercializationWhile in their early-stage development of a mAb biosimilar for oncology treatment, a large biopharmaceuticals company sought a packaging recommendation: a stopper to maintain high-quality standards.
-
![Scientist research laboratory pipette GettyImages-487041629]( "Overcoming The Complex Logistics Of Autologous Cell Therapy Trials: A Deep Dive Into Challenges And Solutions")
Overcoming The Complex Logistics Of Autologous Cell Therapy Trials: A Deep Dive Into Challenges And SolutionsExplore critical logistical requirements in autologous cell therapies logistics and learn how to overcome challenges and achieve successful and timely autologous cell therapy trials.
-
![deadlines time management-GettyImages-1350531674]( "How Modern RTSM Platforms Are Eliminating Delays")
How Modern RTSM Platforms Are Eliminating DelaysStop letting rigid legacy RTSM systems stall your clinical trials. Learn why manual change requests cause months of delays and how a modern, platform-based approach restores your study’s agility.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
